ScoreWhy is Medexus Pharmaceuticals, Inc. ?
1
- NET PROFIT(Q) At CAD 1.39 MM has Fallen at -60.51%
- ROCE(HY) Lowest at 1.88%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.45%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Medexus Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Medexus Pharmaceuticals, Inc.
27.13%
0.05
67.45%
S&P/TSX 60
23.72%
1.54
14.62%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.37%
EBIT Growth (5y)
0.43%
EBIT to Interest (avg)
0.69
Debt to EBITDA (avg)
3.02
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
1.37
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
10.66%
ROE (avg)
4.69%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.47
EV to EBIT
28.35
EV to EBITDA
6.72
EV to Capital Employed
1.39
EV to Sales
0.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.92%
ROE (Latest)
-1.22%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 19.87 %
INTEREST COVERAGE RATIO(Q)
Highest at 536.52
RAW MATERIAL COST(Y)
Fallen by -5.84% (YoY
-18What is not working for the Company
NET PROFIT(Q)
At CAD 0.26 MM has Fallen at -85.06%
OPERATING CASH FLOW(Y)
Lowest at CAD 20.89 MM
ROCE(HY)
Lowest at -0.67%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.43 times
PRE-TAX PROFIT(Q)
Fallen at -30.62%
Here's what is working for Medexus Pharmaceuticals, Inc.
Interest Coverage Ratio
Highest at 536.52
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio
Lowest at 19.87 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -5.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Medexus Pharmaceuticals, Inc.
Net Profit
At CAD 0.26 MM has Fallen at -85.06%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CAD MM)
Inventory Turnover Ratio
Lowest at 1.43 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Cash Flow
Lowest at CAD 20.89 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CAD MM)
Pre-Tax Profit
Fallen at -30.62%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CAD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
